Residency · Galveston, TX
Sponsored by University of Texas Medical Branch Hospitals
Epidemiology, Screening, and Prevention of Bladder Cancer.
European urology oncology · 2022 · 304 citations · Stephen Williams
Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials.
European urology · 2023 · 92 citations · Stephen Williams
Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study.
International journal of impotence research · 2025 · 32 citations · Corey Able, Ali Nasrallah, Joseph Sonstein, Laith Alzweri
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
The Journal of urology · 2023 · 35 citations · Jeffrey Spier
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort.
The Journal of urology · 2025 · 31 citations · Stephen Williams
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.
European urology oncology · 2022 · 83 citations · Stephen Williams
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.
Urologic oncology · 2025 · 21 citations · Stephen Williams
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.
European urology · 2026 · 8 citations · Stephen Williams